317 related articles for article (PubMed ID: 32293530)
61. Detection of anti-citrullinated protein antibody (ACPA) in saliva for rheumatoid arthritis using DBA mice infected with Porphyromonas gingivalis.
Sakaguchi W; To M; Yamamoto Y; Inaba K; Yakeishi M; Saruta J; Fuchida S; Hamada N; Tsukinoki K
Arch Oral Biol; 2019 Dec; 108():104510. PubMed ID: 31446118
[TBL] [Abstract][Full Text] [Related]
62. Elevated Anti-Citrullinated Protein Antibodies Prior to Rheumatoid Arthritis Diagnosis and Risks for Chronic Obstructive Pulmonary Disease or Asthma.
Zaccardelli A; Liu X; Ford JA; Cui J; Lu B; Chu SH; Schur PH; Speyer CB; Costenbader KH; Robinson WH; Sokolove J; Karlson EW; Camargo CA; Sparks JA
Arthritis Care Res (Hoboken); 2021 Apr; 73(4):498-509. PubMed ID: 31961487
[TBL] [Abstract][Full Text] [Related]
63. The isotype and IgG subclass distribution of anti-carbamylated protein antibodies in rheumatoid arthritis patients.
van Delft MAM; Verheul MK; Burgers LE; Derksen VFAM; van der Helm-van Mil AHM; van der Woude D; Huizinga TWJ; Toes REM; Trouw LA
Arthritis Res Ther; 2017 Aug; 19(1):190. PubMed ID: 28810902
[TBL] [Abstract][Full Text] [Related]
64. An investigation of the added value of an ACPA multiplex assay in an early rheumatoid arthritis setting.
van Heemst J; Trouw LA; Nogueira L; van Steenbergen HW; van der Helm-van Mil AH; Allaart CF; Serre G; Holmdahl R; Huizinga TW; Toes RE; van der Woude D
Arthritis Res Ther; 2015 Oct; 17():276. PubMed ID: 26437716
[TBL] [Abstract][Full Text] [Related]
65. Serum matrix metalloproteinase-3 as predictor of joint destruction in rheumatoid arthritis, treated with non-biological disease modifying anti-rheumatic drugs.
Mamehara A; Sugimoto T; Sugiyama D; Morinobu S; Tsuji G; Kawano S; Morinobu A; Kumagai S
Kobe J Med Sci; 2010 Sep; 56(3):E98-107. PubMed ID: 21063156
[TBL] [Abstract][Full Text] [Related]
66. Autoantibodies are major predictors of arthritis development in patients with anti-citrullinated protein antibodies and musculoskeletal pain.
Eloff E; Martinsson K; Ziegelasch M; Cedergren J; Reckner Å; Skogh T; Karlsson L; Ärlemalm A; Borggreven NV; Trouw LA; Kastbom A
Scand J Rheumatol; 2021 May; 50(3):189-197. PubMed ID: 33243072
[No Abstract] [Full Text] [Related]
67. Anti-Citrullinated Protein Antibody Specificities, Rheumatoid Factor Isotypes, and Incident Cardiovascular Events in Patients With Rheumatoid Arthritis.
Westerlind H; Rönnelid J; Hansson M; Alfredsson L; Mathsson-Alm L; Serre G; Cornillet M; Holmdahl R; Jakobsson PJ; Skriner K; Klareskog L; Saevarsdottir S; Askling J
Arthritis Rheumatol; 2020 Oct; 72(10):1658-1667. PubMed ID: 32475073
[TBL] [Abstract][Full Text] [Related]
68. Secretory anti-citrullinated protein antibodies in serum associate with lung involvement in early rheumatoid arthritis.
Roos Ljungberg K; Joshua V; Skogh T; Eklund A; Sköld CM; Karimi R; Nyrén S; Svärd A; Catrina AI; Kastbom A
Rheumatology (Oxford); 2020 Apr; 59(4):852-859. PubMed ID: 31504962
[TBL] [Abstract][Full Text] [Related]
69. Anti-CarP antibodies as promising marker to measure joint damage and disease activity in patients with rheumatoid arthritis.
Yee A; Webb T; Seaman A; Infantino M; Meacci F; Manfredi M; Benucci M; Lakos G; Favalli E; Schioppo T; Meroni PL; Mahler M
Immunol Res; 2015 Feb; 61(1-2):24-30. PubMed ID: 25391608
[TBL] [Abstract][Full Text] [Related]
70. Association between anti-Porphyromonas gingivalis antibody, anti-citrullinated protein antibodies, and rheumatoid arthritis : A meta-analysis.
Bae SC; Lee YH
Z Rheumatol; 2018 Aug; 77(6):522-532. PubMed ID: 28555277
[TBL] [Abstract][Full Text] [Related]
71. Association of anti-cyclic citrullinated peptide antibodies and rheumatoid factor isotypes with HLA-DRB1 shared epitope alleles in Egyptian rheumatoid arthritis patients.
Raslan HM; Attia HR; Hamed Ibrahim M; Mahmoud Hassan E; Salama II; Ismail S; Abdelmotaleb E; El Menyawi MM; Amr KS
Int J Rheum Dis; 2020 May; 23(5):647-653. PubMed ID: 32167241
[TBL] [Abstract][Full Text] [Related]
72. Reverse expression of α2,6-sialic acid ratios on IgG, IgM, and IgG/IgM autoantibodies correlates with mouse arthritis and rheumatoid arthritis disease activity.
Liou LB; Huang CC
J Chin Med Assoc; 2020 Dec; 83(12):1079-1086. PubMed ID: 33009208
[TBL] [Abstract][Full Text] [Related]
73. APRIL Level as a Marker of Disease Activity in Treated Rheumatoid Arthritis Patients: Association with Disease Activity and Anti-CCP Antibody.
Boghdadi G; El-Sokkary RH; Elewa EA; Abbas SF
Egypt J Immunol; 2015 Jun; 22(2):31-39. PubMed ID: 28502142
[TBL] [Abstract][Full Text] [Related]
74. Serum RANKL levels associate with anti- citrullinated protein antibodies in early untreated rheumatoid arthritis and are modulated following methotrexate.
Hensvold AH; Joshua V; Li W; Larkin M; Qureshi F; Israelsson L; Padyukov L; Lundberg K; Defranoux N; Saevarsdottir S; Catrina AI
Arthritis Res Ther; 2015 Sep; 17(1):239. PubMed ID: 26337028
[TBL] [Abstract][Full Text] [Related]
75. Diagnostic performance of a new vimentin-derived ACPA (CCP high sensitive) in patients with rheumatoid arthritis.
Bertin D; Dubucquoi S; Lakomy D; Deleplancque AS; Desplat-Jégo S
Immunol Res; 2016 Apr; 64(2):455-60. PubMed ID: 26350265
[TBL] [Abstract][Full Text] [Related]
76. Elevated serum IL-35 levels in rheumatoid arthritis are associated with disease activity.
Li Y; Yao L; Liu S; Wu J; Xia L; Shen H; Lu J
J Investig Med; 2019 Mar; 67(3):707-710. PubMed ID: 30659089
[TBL] [Abstract][Full Text] [Related]
77. Cost per response for abatacept versus adalimumab in rheumatoid arthritis by ACPA subgroups in Germany, Italy, Spain, US and Canada.
Weijers L; Baerwald C; Mennini FS; Rodríguez-Heredia JM; Bergman MJ; Choquette D; Herrmann KH; Attinà G; Nappi C; Merino SJ; Patel C; Mtibaa M; Foo J
Rheumatol Int; 2017 Jul; 37(7):1111-1123. PubMed ID: 28560470
[TBL] [Abstract][Full Text] [Related]
78. Comparative analysis of autoantibodies targeting peptidylarginine deiminase type 4, mutated citrullinated vimentin and cyclic citrullinated peptides in rheumatoid arthritis: associations with cytokine profiles, clinical and genetic features.
Reyes-Castillo Z; Palafox-Sánchez CA; Parra-Rojas I; Martínez-Bonilla GE; del Toro-Arreola S; Ramírez-Dueñas MG; Ocampo-Bermudes G; Muñoz-Valle JF
Clin Exp Immunol; 2015 Nov; 182(2):119-31. PubMed ID: 26149185
[TBL] [Abstract][Full Text] [Related]
79. [Elevated serum IL-25 levels in rheumatoid arthritis patients with bone erosion and interstitial lung disease].
Lu J; DA M; Feng Y; Liu Y; Zhang S; Shen H
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2017 Aug; 33(8):1118-1122. PubMed ID: 28871954
[TBL] [Abstract][Full Text] [Related]
80. N-Linked Glycans in the Variable Domain of IgG Anti-Citrullinated Protein Antibodies Predict the Development of Rheumatoid Arthritis.
Hafkenscheid L; de Moel E; Smolik I; Tanner S; Meng X; Jansen BC; Bondt A; Wuhrer M; Huizinga TWJ; Toes REM; El-Gabalawy H; Scherer HU
Arthritis Rheumatol; 2019 Oct; 71(10):1626-1633. PubMed ID: 31067000
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
